Candel Therapeutics shares owned by Bridgeway Capital Management
Quarter-by-quarter ownership of Candel Therapeutics (CADL) shares owned by Bridgeway Capital Management
from 13F filings
Historical chart of Bridgeway Capital Management investment in Candel Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Candel Therapeutics held by Bridgeway Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Candel Therapeutics by Bridgeway Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $281k | 55k | 5.10 |
| 2025-06-30 | $279k | 55k | 5.06 |
| 2024-12-31 | $670k | 77k | 8.68 |
| 2024-09-30 | $559k | 81k | 6.93 |
| 2024-06-30 | $500k | 81k | 6.20 |
| 2024-03-31 | $131k | 83k | 1.58 |
| 2023-09-30 | $123k | 133k | 0.93 |
| 2023-06-30 | $167k | 133k | 1.26 |
| 2023-03-31 | $182k | 133k | 1.37 |
| 2022-12-31 | $238k | 133k | 1.79 |
| 2022-09-30 | $417k | 133k | 3.14 |
| 2022-06-30 | $430k | 133k | 3.24 |
| 2022-03-31 | $382k | 75k | 5.09 |
More positions owned by Bridgeway Capital Management
View all positions for Bridgeway Capital Management